Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles
- PMID: 2947237
- PMCID: PMC387025
- DOI: 10.1073/pnas.83.23.8824
Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles
Abstract
Neurohypophysial hormones stimulate the motility of tunica albuginea, epididymis, and vas deferens acting through oxytocin (OT) and V1 vasopressin receptors. To test the hypothesis that these hormones are involved also in the regulation of seminal vesicle physiology, we studied binding of [3H]OT and [3H] arginine vasopressin ([3H]AVP) to porcine seminal vesicle membranes. Neurohypophysial hormones bind to two different classes of sites. The first class shows low capacity (35 fmol per mg of protein) and a very high affinity (Kd less than 1 nM) for both the labeled ligands. The second class is characterized by a high capacity (2000 fmol per mg of protein) and a high affinity for AVP (Kd approximately equal to 2.5 nM), whereas OT has 160 times lower affinity. Lysine vasopressin and the V1 antagonist [1-deaminopenicillamine, 2-(O-methyl)tyrosine]Arg8-vasopressin compete with high affinity with [3H]AVP binding, whereas the V2 agonist [1-deamino,4-valine]D-Arg8-vasopressin (dVDAVP) is 110 times less potent than AVP. The OT agonist [Thr4,Gly7]OT and the OT antagonist [1(beta-mercapto-beta, beta-cyclopentamethylene propionic acid), 2-(O-ethyl)tyrosine, 8-ornithine]vasotocin failed to affect [3H]AVP binding. These findings seem to suggest that AVP interacts with the V1 vasopressin isoreceptor in porcine seminal vesicle membranes. However, AVP stimulates adenylate cyclase activity in a dose-dependent fashion with an EC50 of 14 nM, whereas OT or dVDAVP has no effect at 100 nM. Moreover, a well-characterized V1 vasopressin antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylene propionic acid),2-(O-methyl)tyrosine]Arg8-vasopressin [d(CH2)5Tyr(Me)AVP], competes with [3H]AVP binding with an IC50 of 0.17 microM. These pharmacological properties are distinct from the previously described V1 and V2 vasopressin receptors and indicate the presence of a new class of AVP receptors. Although this vasopressin isoreceptor shares some pharmacological characteristics with the V1 (pressor) isoreceptor, it has low affinity for the V1 antagonist d(CH2)5-Tyr(Me)AVP and is linked to the adenylate cyclase system. The extremely high density of AVP receptors in porcine seminal vesicles (2 pmol per mg of protein) is comparable to the density of V2 vasopressin receptors in porcine renal medulla, suggesting a physiological role for vasopressin in the seminal vesicle.
Similar articles
-
Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens.Endocrinology. 1987 Mar;120(3):986-94. doi: 10.1210/endo-120-3-986. Endocrinology. 1987. PMID: 3026794
-
Vasopressin receptors in human seminal vesicles: identification, pharmacologic characterization, and comparison with the vasopressin receptors present in the human kidney.J Androl. 1989 Sep-Oct;10(5):393-400. doi: 10.1002/j.1939-4640.1989.tb00126.x. J Androl. 1989. PMID: 2592268
-
Identification and characterization of arginine vasopressin receptors in the rat testis.Endocrinology. 1985 Jan;116(1):416-23. doi: 10.1210/endo-116-1-416. Endocrinology. 1985. PMID: 2981073
-
Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.Adv Exp Med Biol. 1998;449:371-85. doi: 10.1007/978-1-4615-4871-3_48. Adv Exp Med Biol. 1998. PMID: 10026828 Review.
-
Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays.Exp Physiol. 2000 Mar;85 Spec No:7S-18S. doi: 10.1111/j.1469-445x.2000.tb00003.x. Exp Physiol. 2000. PMID: 10795902 Review.
Cited by
-
Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.Cell Mol Neurobiol. 1995 Oct;15(5):573-95. doi: 10.1007/BF02071318. Cell Mol Neurobiol. 1995. PMID: 8719042 Free PMC article. Review.
-
Normal male sexual function: emphasis on orgasm and ejaculation.Fertil Steril. 2015 Nov;104(5):1051-60. doi: 10.1016/j.fertnstert.2015.08.033. Epub 2015 Sep 16. Fertil Steril. 2015. PMID: 26385403 Free PMC article. Review.
-
Hormonal and local regulation of uterine activity during parturition: Part I--The oxytocin system.J Endocrinol Invest. 1994 Oct;17(9):739-56. doi: 10.1007/BF03347771. J Endocrinol Invest. 1994. PMID: 7868820 Review. No abstract available.
-
The hormonal control of ejaculation.Nat Rev Urol. 2012 Sep;9(9):508-19. doi: 10.1038/nrurol.2012.147. Epub 2012 Aug 7. Nat Rev Urol. 2012. PMID: 22869001 Review.
-
Mitotic activity and cell deletion in ventral prostate epithelium of intact and castrated oxytocin-treated rats.J Endocrinol Invest. 1992 Apr;15(4):249-53. doi: 10.1007/BF03348721. J Endocrinol Invest. 1992. PMID: 1512414
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous